Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Pyridine | HCID 1049 | — |
| Reactant | 1-Methylpiperazine | HCID 53167 | — |
| Reactant | HCID 13603466 | HCID 13603466 | — |
| Solvent | Ethanol | HCID 702 | — |
| Solvent | Chloroform | HCID 6212 | — |
| Product | HCID 13885773 | HCID 13885773 | — |
Reaction Steps
1.0 g (3.0 mMole) methyl (±)-1,4-dihydro-5-isopropoxy-2-methyl-4-phenyl-1,6-naphthyridine-3-carboxylate (for the preparation cf. Federal Republic of Germany Patent Specification No. 34 31 303) in ethanol-free chloroform is cooled to -10° C., mixed with 0.26 ml (3.2 mMole) pyridine and subsequently portionwise with 1.1 g (3.1 mMole) pyridinium bromide perbromide (90%). After 30 minutes at -10° C., 0.62 g (6.2 mMole) N-methylpiperazine is added dropwise thereto and the reaction mixture is stirred for 15 minutes at -10° C. and then warmed to 20° C. within the course of one hour. The reaction mixture is diluted with chloroform, washed with water and the organic phase is dried over anhydrous sodium sulphate. The residue obtained after distilling off the solvent is chromatographed on silica gel with dichloromethane/methanol (9:1 v/v). The fraction with the Rf of 0.3 is recrystallized from n-hexane. There is obtained methyl (±)-1,4-dihydro-5 -isopropoxy-2-[(4-methyl-piperazin-l-yl)-methyl]-4-phenyl-1,6-naphthyridine-3-carboxylate in the form of colorless crystals; mp 149°-151° C.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US04751228 |
|---|
| Source dataset | uspto-grants-1988_06 |
|---|
| ORD ID | ord-6d6466f8b2fb4c0992689456f6b874fc |
|---|
| Source note | uspto-grants-1988_06 |
|---|